|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
0.47/1.24
|
Enterprise Value
22.10B
|
Balance Sheet |
Book Value Per Share
7.86
|
Cash Flow |
Cash Flow Yield
0.05
|
Income Statement |
Total Revenue
6.97B
|
Operating Revenue Per Share
10.36
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/05/11 18:01 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Avantor Inc is involved in providing products and services to biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's offerings include materials and consumables, equipmentand instrumentation and services and specialty procurement. Its brand profile consists of NuSil, RANKEM, POCH, BeneSphera, and Macron Fine Chemicals among others. The firm operates in three geographical segments namely Americas, Europe, and AMEA. It generates a majority of its revenue from the Americas. |